Results 11 to 20 of about 1,206,636 (268)
Lipids and Renal Disease [PDF]
Journal of the American Society of Nephrology, 2006 Chronic renal disease is accompanied by characteristic abnormalities of lipid metabolism, which appear as a consequence of nephrotic syndrome or renal insufficiency and are reflected in an altered apolipoprotein profile as well as elevated plasma lipid levels.
Trevisan R, Dodesini AR, Lepore G
openaire +2 more sources
International Journal of Endocrinology, 2014 Diabetic nephropathy (DN) is an important long-term complication of diabetes. DN is now the most common cause of end-stage renal disease (ESRD) in many countries [1]. Both the increasing prevalence of type 2 DM and increased acceptance of diabetic patients into renal replacement therapy (RRT) programmes have contributed to this.
Stephen Fava, Samy Hadjadj, James Walker
openaire +4 more sources
Microbiota, renal disease and renal transplantation
World Journal of Transplantation, 2021 Aim of this frontier review has been to highlight the role of microbiota in healthy subjects and in patients affected by renal diseases with particular reference to renal transplantation. The microbiota has a relevant role in conditioning the healthy status and the diseases.
Salvadori, Maurizio, Tsalouchos, Aris
openaire +2 more sources
Renal Disease in Cryoglobulinemia [PDF]
Glomerular Diseases, 2021 <b><i>Background:</i></b> Renal disease in cryoglobulinemia is difficult to grasp and diagnose because it is rare, serological testing is challenging and prone to artifacts, and its morphology is shared by other renal diseases resulting in a spectrum of differential diagnoses.
Thomas Menter, Helmut Hopfer
openaire +2 more sources
BMC Nephrology, 2019 Background Hydroxychloroquine (HCQ), a well-known immunomodulator, has recently been found to be a promising and safe anti-proteinuric agent for treating IgA nephropathy (IgAN).
Ya-zi Yang +7 more
doaj +1 more source
The complement system and autoimmune diseases
Chronic Diseases and Translational Medicine, 2022 The complement system plays a key role in the pathogenesis of autoimmune diseases, which usually injures the kidney. More and more studies have shown the pathogenic role and indicated that abnormal activation of the complement system was highly involved ...
Changhao Jia, Ying Tan, Minghui Zhao
doaj +1 more source
Arthritis Research & Therapy, 2017 Background Our previous study found that circulating and urinary levels of high mobility group box-1 (HMGB1) were closely associated with disease activity in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Hui Deng +5 more
doaj +1 more source
Macrophages in Renal Disease [PDF]
Journal of the American Society of Nephrology, 2011 Macrophages have heterogeneous phenotypes as they exercise their twofold role in the development and recovery of renal diseases. Some subpopulations of macrophages (M1) have a pathogenic function in renal inflammation, making them a logical target for elimination.
Yiping, Wang, David C H, Harris
openaire +2 more sources
Quantification of proteinuria in mild preeclampsia with random albumin creatinine ratio
African Journal of Nephrology, 2010 Objective: To investigate the whether spot urinealbumin/creatinine ratio (ACR) compared to the 24hurinary protein (gold standard) to detect significantproteinuria in patients with preeclampsia.
Ahmad Aziz +3 more
doaj +1 more source
Frontiers in Genetics, 2021 Both IgA nephropathy (IgAN) and lupus nephritis (LN) are immunity-related diseases with a complex, polygenic, and pleiotropic genetic architecture. However, the mechanism by which the genetic variants impart immunity or renal dysfunction remains to be ...
Ni-Ya Jia +11 more
doaj +1 more source